PARSIPPANY, N.J., April 09, 2019 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (“Pacira”) (NASDAQ: PCRX) today announced that it has completed its previously announced acquisition of MyoScience, Inc. (“MyoScience”), a privately held medical technology company. This acquisition advances the company’s leadership in non-opioid pain management by adding the FDA-approved ioveraº system to the Pacira commercial offering. The ioveraº …